UniProt ID | ZN148_HUMAN | |
---|---|---|
UniProt AC | Q9UQR1 | |
Protein Name | Zinc finger protein 148 | |
Gene Name | ZNF148 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 794 | |
Subcellular Localization | Nucleus. | |
Protein Description | Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes.. | |
Protein Sequence | MNIDDKLEGLFLKCGGIDEMQSSRTMVVMGGVSGQSTVSGELQDSVLQDRSMPHQEILAADEVLQESEMRQQDMISHDELMVHEETVKNDEEQMETHERLPQGLQYALNVPISVKQEITFTDVSEQLMRDKKQIREPVDLQKKKKRKQRSPAKILTINEDGSLGLKTPKSHVCEHCNAAFRTNYHLQRHVFIHTGEKPFQCSQCDMRFIQKYLLQRHEKIHTGEKPFRCDECGMRFIQKYHMERHKRTHSGEKPYQCEYCLQYFSRTDRVLKHKRMCHENHDKKLNRCAIKGGLLTSEEDSGFSTSPKDNSLPKKKRQKTEKKSSGMDKESALDKSDLKKDKNDYLPLYSSSTKVKDEYMVAEYAVEMPHSSVGGSHLEDASGEIHPPKLVLKKINSKRSLKQPLEQNQTISPLSTYEESKVSKYAFELVDKQALLDSEGNADIDQVDNLQEGPSKPVHSSTNYDDAMQFLKKKRYLQAASNNSREYALNVGTIASQPSVTQAAVASVIDESTTASILESQALNVEIKSNHDKNVIPDEVLQTLLDHYSHKANGQHEISFSVADTEVTSSISINSSEVPEVTPSENVGSSSQASSSDKANMLQEYSKFLQQALDRTSQNDAYLNSPSLNFVTDNQTLPNQPAFSSIDKQVYATMPINSFRSGMNSPLRTTPDKSHFGLIVGDSQHSFPFSGDETNHASATSTQDFLDQVTSQKKAEAQPVHQAYQMSSFEQPFRAPYHGSRAGIATQFSTANGQVNLRGPGTSAEFSEFPLVNVNDNRAGMTSSPDATTGQTFG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Sumoylation | --MNIDDKLEGLFLK --CCHHHHHHHHHHH | 44.69 | 28112733 | |
22 | Phosphorylation | GGIDEMQSSRTMVVM CCCCHHHCCCEEEEE | 22.07 | 21955146 | |
23 | Phosphorylation | GIDEMQSSRTMVVMG CCCHHHCCCEEEEEC | 18.19 | 21955146 | |
25 | Phosphorylation | DEMQSSRTMVVMGGV CHHHCCCEEEEECCC | 19.10 | 18669648 | |
33 | Phosphorylation | MVVMGGVSGQSTVSG EEEECCCCCCCCCCH | 34.10 | 21955146 | |
36 | Phosphorylation | MGGVSGQSTVSGELQ ECCCCCCCCCCHHHC | 34.01 | 21955146 | |
37 | Phosphorylation | GGVSGQSTVSGELQD CCCCCCCCCCHHHCC | 15.71 | 18669648 | |
39 | Phosphorylation | VSGQSTVSGELQDSV CCCCCCCCHHHCCHH | 27.00 | 21955146 | |
45 | Phosphorylation | VSGELQDSVLQDRSM CCHHHCCHHHCCCCC | 16.27 | 21955146 | |
51 | Phosphorylation | DSVLQDRSMPHQEIL CHHHCCCCCCHHHHH | 44.98 | 30108239 | |
88 | Sumoylation | MVHEETVKNDEEQME HCCHHHCCCHHHHHH | 67.13 | 28112733 | |
106 | Phosphorylation | RLPQGLQYALNVPIS HCCCHHHHHHCCCEE | 20.35 | 27642862 | |
115 | Sumoylation | LNVPISVKQEITFTD HCCCEEECEEEEECC | 35.11 | - | |
115 | Sumoylation | LNVPISVKQEITFTD HCCCEEECEEEEECC | 35.11 | 28112733 | |
119 | Phosphorylation | ISVKQEITFTDVSEQ EEECEEEEECCHHHH | 21.52 | 20860994 | |
121 | Phosphorylation | VKQEITFTDVSEQLM ECEEEEECCHHHHHH | 27.17 | 20860994 | |
132 | Sumoylation | EQLMRDKKQIREPVD HHHHCCHHHHCCCCC | 56.07 | - | |
132 | Sumoylation | EQLMRDKKQIREPVD HHHHCCHHHHCCCCC | 56.07 | 28112733 | |
147 | Ubiquitination | LQKKKKRKQRSPAKI HHHHHHHCCCCCCCE | 59.97 | 23000965 | |
150 | Phosphorylation | KKKRKQRSPAKILTI HHHHCCCCCCCEEEE | 27.07 | 25849741 | |
153 | Ubiquitination | RKQRSPAKILTINED HCCCCCCCEEEECCC | 41.45 | 23000965 | |
156 | Phosphorylation | RSPAKILTINEDGSL CCCCCEEEECCCCCC | 25.81 | 21949786 | |
162 | Phosphorylation | LTINEDGSLGLKTPK EEECCCCCCCCCCCC | 31.42 | 27251275 | |
166 | Ubiquitination | EDGSLGLKTPKSHVC CCCCCCCCCCCCHHH | 62.07 | 29967540 | |
167 | Phosphorylation | DGSLGLKTPKSHVCE CCCCCCCCCCCHHHH | 40.78 | 22199227 | |
194 | Phosphorylation | QRHVFIHTGEKPFQC CCCEEEECCCCCCCC | 42.07 | 30576142 | |
197 | Ubiquitination | VFIHTGEKPFQCSQC EEEECCCCCCCCCHH | 53.10 | - | |
202 | Phosphorylation | GEKPFQCSQCDMRFI CCCCCCCCHHCHHHH | 24.06 | 30576142 | |
222 | Phosphorylation | QRHEKIHTGEKPFRC HHHHCCCCCCCCCCC | 50.97 | 29496963 | |
239 | Sumoylation | CGMRFIQKYHMERHK HHHHHHHHHHHHHHC | 32.10 | - | |
239 | Ubiquitination | CGMRFIQKYHMERHK HHHHHHHHHHHHHHC | 32.10 | 29967540 | |
239 | Sumoylation | CGMRFIQKYHMERHK HHHHHHHHHHHHHHC | 32.10 | - | |
248 | Phosphorylation | HMERHKRTHSGEKPY HHHHHCCCCCCCCCC | 25.79 | 28152594 | |
250 | Phosphorylation | ERHKRTHSGEKPYQC HHHCCCCCCCCCCCC | 48.29 | 26055452 | |
255 | Phosphorylation | THSGEKPYQCEYCLQ CCCCCCCCCCHHHHH | 36.54 | 29214152 | |
259 | Phosphorylation | EKPYQCEYCLQYFSR CCCCCCHHHHHHHHH | 13.19 | - | |
291 | Methylation | KLNRCAIKGGLLTSE HHHHHHEECCCCCCC | 28.53 | 115978281 | |
291 | Ubiquitination | KLNRCAIKGGLLTSE HHHHHHEECCCCCCC | 28.53 | 23000965 | |
291 | Acetylation | KLNRCAIKGGLLTSE HHHHHHEECCCCCCC | 28.53 | 26051181 | |
291 | Sumoylation | KLNRCAIKGGLLTSE HHHHHHEECCCCCCC | 28.53 | 28112733 | |
296 | Phosphorylation | AIKGGLLTSEEDSGF HEECCCCCCCCCCCC | 38.85 | 23927012 | |
297 | Phosphorylation | IKGGLLTSEEDSGFS EECCCCCCCCCCCCC | 38.67 | 25159151 | |
301 | Phosphorylation | LLTSEEDSGFSTSPK CCCCCCCCCCCCCCC | 45.04 | 22167270 | |
304 | Phosphorylation | SEEDSGFSTSPKDNS CCCCCCCCCCCCCCC | 31.34 | 29255136 | |
305 | Phosphorylation | EEDSGFSTSPKDNSL CCCCCCCCCCCCCCC | 46.95 | 29255136 | |
306 | Phosphorylation | EDSGFSTSPKDNSLP CCCCCCCCCCCCCCC | 28.84 | 29255136 | |
308 | Sumoylation | SGFSTSPKDNSLPKK CCCCCCCCCCCCCHH | 70.12 | 28112733 | |
311 | Phosphorylation | STSPKDNSLPKKKRQ CCCCCCCCCCHHHHH | 57.07 | 22167270 | |
324 | Phosphorylation | RQKTEKKSSGMDKES HHHHCHHCCCCCHHH | 43.10 | 29214152 | |
325 | Phosphorylation | QKTEKKSSGMDKESA HHHCHHCCCCCHHHH | 47.20 | - | |
329 | Acetylation | KKSSGMDKESALDKS HHCCCCCHHHHCCHH | 44.68 | 25953088 | |
331 | Phosphorylation | SSGMDKESALDKSDL CCCCCHHHHCCHHHH | 39.61 | - | |
335 | Acetylation | DKESALDKSDLKKDK CHHHHCCHHHHHCCC | 46.87 | 25953088 | |
336 | Phosphorylation | KESALDKSDLKKDKN HHHHCCHHHHHCCCC | 48.09 | 25159151 | |
342 | Ubiquitination | KSDLKKDKNDYLPLY HHHHHCCCCCCCCCC | 61.67 | 29967540 | |
342 | Acetylation | KSDLKKDKNDYLPLY HHHHHCCCCCCCCCC | 61.67 | 25953088 | |
345 | Phosphorylation | LKKDKNDYLPLYSSS HHCCCCCCCCCCCCC | 21.44 | 27642862 | |
349 | Phosphorylation | KNDYLPLYSSSTKVK CCCCCCCCCCCCCCC | 12.45 | 27642862 | |
350 | Phosphorylation | NDYLPLYSSSTKVKD CCCCCCCCCCCCCCC | 26.04 | 25159151 | |
351 | Phosphorylation | DYLPLYSSSTKVKDE CCCCCCCCCCCCCCE | 28.59 | 25159151 | |
352 | Phosphorylation | YLPLYSSSTKVKDEY CCCCCCCCCCCCCEE | 26.72 | 25159151 | |
353 | Phosphorylation | LPLYSSSTKVKDEYM CCCCCCCCCCCCEEE | 41.63 | 25627689 | |
356 | Sumoylation | YSSSTKVKDEYMVAE CCCCCCCCCEEEEEE | 46.53 | - | |
356 | Sumoylation | YSSSTKVKDEYMVAE CCCCCCCCCEEEEEE | 46.53 | 25114211 | |
400 | Phosphorylation | KKINSKRSLKQPLEQ HHCCCCCCCCCCHHC | 43.59 | 23403867 | |
402 | Ubiquitination | INSKRSLKQPLEQNQ CCCCCCCCCCHHCCC | 51.63 | 29967540 | |
402 | Sumoylation | INSKRSLKQPLEQNQ CCCCCCCCCCHHCCC | 51.63 | 28112733 | |
410 | Phosphorylation | QPLEQNQTISPLSTY CCHHCCCCCCCCHHH | 30.85 | 30266825 | |
412 | Phosphorylation | LEQNQTISPLSTYEE HHCCCCCCCCHHHCH | 24.15 | 23927012 | |
415 | Phosphorylation | NQTISPLSTYEESKV CCCCCCCHHHCHHHH | 32.12 | 30266825 | |
416 | Phosphorylation | QTISPLSTYEESKVS CCCCCCHHHCHHHHH | 42.51 | 30266825 | |
417 | Phosphorylation | TISPLSTYEESKVSK CCCCCHHHCHHHHHH | 17.83 | 30266825 | |
420 | Phosphorylation | PLSTYEESKVSKYAF CCHHHCHHHHHHHHH | 26.81 | 23927012 | |
421 | Ubiquitination | LSTYEESKVSKYAFE CHHHCHHHHHHHHHH | 54.53 | 29967540 | |
421 | Acetylation | LSTYEESKVSKYAFE CHHHCHHHHHHHHHH | 54.53 | 26051181 | |
421 | Sumoylation | LSTYEESKVSKYAFE CHHHCHHHHHHHHHH | 54.53 | 28112733 | |
423 | Phosphorylation | TYEESKVSKYAFELV HHCHHHHHHHHHHHH | 24.56 | 23312004 | |
424 | Sumoylation | YEESKVSKYAFELVD HCHHHHHHHHHHHHH | 43.52 | - | |
424 | Ubiquitination | YEESKVSKYAFELVD HCHHHHHHHHHHHHH | 43.52 | 29967540 | |
424 | Sumoylation | YEESKVSKYAFELVD HCHHHHHHHHHHHHH | 43.52 | 28112733 | |
424 | Acetylation | YEESKVSKYAFELVD HCHHHHHHHHHHHHH | 43.52 | 25953088 | |
425 | Phosphorylation | EESKVSKYAFELVDK CHHHHHHHHHHHHHH | 14.71 | - | |
432 | Ubiquitination | YAFELVDKQALLDSE HHHHHHHHHHHHCCC | 29.95 | 29967540 | |
438 | Phosphorylation | DKQALLDSEGNADID HHHHHHCCCCCCCHH | 47.58 | 25159151 | |
456 | Acetylation | NLQEGPSKPVHSSTN CCCCCCCCCCCCCCC | 54.94 | 25953088 | |
456 | Ubiquitination | NLQEGPSKPVHSSTN CCCCCCCCCCCCCCC | 54.94 | 29967540 | |
472 | Ubiquitination | DDAMQFLKKKRYLQA HHHHHHHHHHHHHHH | 58.50 | 29967540 | |
496 | O-linked_Glycosylation | LNVGTIASQPSVTQA ECHHHCCCCCCHHHH | 38.48 | 31492838 | |
501 | O-linked_Glycosylation | IASQPSVTQAAVASV CCCCCCHHHHHHHHH | 19.48 | 31492838 | |
533 | Ubiquitination | EIKSNHDKNVIPDEV EECCCCCCCCCCHHH | 45.63 | 29967540 | |
533 | Acetylation | EIKSNHDKNVIPDEV EECCCCCCCCCCHHH | 45.63 | 26051181 | |
543 | Phosphorylation | IPDEVLQTLLDHYSH CCHHHHHHHHHHHCH | 25.73 | 27251275 | |
549 | Phosphorylation | QTLLDHYSHKANGQH HHHHHHHCHHHCCCE | 18.32 | 27251275 | |
559 | O-linked_Glycosylation | ANGQHEISFSVADTE HCCCEEEEEEECCCE | 14.42 | 31492838 | |
572 | O-linked_Glycosylation | TEVTSSISINSSEVP CEEEEEEEECCCCCC | 20.05 | 31492838 | |
607 | Acetylation | NMLQEYSKFLQQALD HHHHHHHHHHHHHHH | 49.55 | 19608861 | |
607 | Ubiquitination | NMLQEYSKFLQQALD HHHHHHHHHHHHHHH | 49.55 | 19608861 | |
625 | Phosphorylation | QNDAYLNSPSLNFVT CCCCCCCCCCCCCCC | 17.17 | 22210691 | |
627 | Phosphorylation | DAYLNSPSLNFVTDN CCCCCCCCCCCCCCC | 35.45 | 22210691 | |
632 | Phosphorylation | SPSLNFVTDNQTLPN CCCCCCCCCCCCCCC | 25.70 | 28348404 | |
636 | Phosphorylation | NFVTDNQTLPNQPAF CCCCCCCCCCCCCCC | 50.89 | 28348404 | |
636 | O-linked_Glycosylation | NFVTDNQTLPNQPAF CCCCCCCCCCCCCCC | 50.89 | 31492838 | |
644 | O-linked_Glycosylation | LPNQPAFSSIDKQVY CCCCCCCCCCCCCCE | 28.61 | 31492838 | |
651 | Phosphorylation | SSIDKQVYATMPINS CCCCCCCEEECCCCH | 8.21 | 28796482 | |
653 | Phosphorylation | IDKQVYATMPINSFR CCCCCEEECCCCHHC | 13.04 | 26074081 | |
658 | Phosphorylation | YATMPINSFRSGMNS EEECCCCHHCCCCCC | 23.82 | 26074081 | |
661 | Phosphorylation | MPINSFRSGMNSPLR CCCCHHCCCCCCCCC | 40.14 | 25159151 | |
665 | Phosphorylation | SFRSGMNSPLRTTPD HHCCCCCCCCCCCCC | 19.20 | 29255136 | |
669 | Phosphorylation | GMNSPLRTTPDKSHF CCCCCCCCCCCCCCC | 50.81 | 25159151 | |
670 | Phosphorylation | MNSPLRTTPDKSHFG CCCCCCCCCCCCCCE | 24.05 | 23401153 | |
683 | Phosphorylation | FGLIVGDSQHSFPFS CEEEECCCCCCCCCC | 24.70 | 26074081 | |
686 | Phosphorylation | IVGDSQHSFPFSGDE EECCCCCCCCCCCCC | 27.29 | 26074081 | |
702 | Phosphorylation | NHASATSTQDFLDQV CCCCCCCHHHHHHHH | 28.01 | 30576142 | |
724 | Phosphorylation | AQPVHQAYQMSSFEQ CCCHHHHHHCCCCCC | 9.74 | 27642862 | |
727 | Phosphorylation | VHQAYQMSSFEQPFR HHHHHHCCCCCCCCC | 19.15 | 28348404 | |
728 | Phosphorylation | HQAYQMSSFEQPFRA HHHHHCCCCCCCCCC | 27.71 | 28348404 | |
734 | Methylation | SSFEQPFRAPYHGSR CCCCCCCCCCCCCCC | 41.14 | 115920397 | |
740 | Phosphorylation | FRAPYHGSRAGIATQ CCCCCCCCCCEEEEE | 12.97 | - | |
749 | Phosphorylation | AGIATQFSTANGQVN CEEEEEEECCCCEEE | 19.45 | 28857561 | |
749 | O-linked_Glycosylation | AGIATQFSTANGQVN CEEEEEEECCCCEEE | 19.45 | 31492838 | |
750 | Phosphorylation | GIATQFSTANGQVNL EEEEEEECCCCEEEE | 25.98 | 28857561 | |
762 | Phosphorylation | VNLRGPGTSAEFSEF EEECCCCCCCCCCCC | 28.09 | 24719451 | |
763 | Phosphorylation | NLRGPGTSAEFSEFP EECCCCCCCCCCCCC | 31.54 | 26714015 | |
767 | Phosphorylation | PGTSAEFSEFPLVNV CCCCCCCCCCCEEEC | 29.81 | 26074081 | |
782 | Phosphorylation | NDNRAGMTSSPDATT CCCCCCCCCCCCCCC | 25.74 | 30266825 | |
783 | Phosphorylation | DNRAGMTSSPDATTG CCCCCCCCCCCCCCC | 30.86 | 30266825 | |
784 | Phosphorylation | NRAGMTSSPDATTGQ CCCCCCCCCCCCCCC | 20.03 | 26846344 | |
788 | Phosphorylation | MTSSPDATTGQTFG- CCCCCCCCCCCCCC- | 38.55 | 30266825 | |
789 | Phosphorylation | TSSPDATTGQTFG-- CCCCCCCCCCCCC-- | 29.07 | 23663014 | |
792 | Phosphorylation | PDATTGQTFG----- CCCCCCCCCC----- | 31.50 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
202 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN148_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN148_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CAVN1_HUMAN | PTRF | physical | 10727401 | |
P53_HUMAN | TP53 | physical | 11416144 | |
HDAC3_HUMAN | HDAC3 | physical | 19583777 | |
EP300_HUMAN | EP300 | physical | 21828133 | |
TRRAP_HUMAN | TRRAP | physical | 21828133 | |
KAT2A_HUMAN | KAT2A | physical | 21828133 | |
ZN316_HUMAN | ZNF316 | physical | 22939629 | |
TRI10_HUMAN | TRIM10 | physical | 25416956 | |
GLRX3_HUMAN | GLRX3 | physical | 25416956 | |
GORS2_HUMAN | GORASP2 | physical | 25416956 | |
NTM2F_HUMAN | NUTM2F | physical | 25416956 | |
CEP70_HUMAN | CEP70 | physical | 25416956 | |
DEUP1_HUMAN | CCDC67 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-607, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306; SER-412 ANDSER-784, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-784, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-194; SER-250; SER-306;SER-412 AND SER-784, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-412, ANDMASS SPECTROMETRY. |